Why the study?
The serum uric acid-to-high-density lipoprotein cholesterol ratio (UHR) has been investigated in relation to CAD, but existing studies differ in their populations, exposure contrasts, and coronary outcomes.
Is a higher serum uric acid-to-high-density lipoprotein cholesterol ratio (UHR) associated with coronary artery disease presence and angiographic disease burden?
Is a higher serum uric acid-to-high-density lipoprotein cholesterol ratio (UHR) associated with coronary artery disease presence and angiographic disease burden?
In observational studies, a higher serum uric acid-to-HDL cholesterol ratio is positively associated with CAD presence and angiographic severity (Gensini and SYNTAX scores), though certainty of evidence is very low and incremental predictive value remains unestablished.
Answers are grounded in this paper and cite their sources.
Higher UHR was associated with CAD presence and angiographic burden in observational data; leaves open causality and incremental predictive value beyond established factors.
Background The uric acid-to-high-density lipoprotein cholesterol ratio (UHR) has been investigated in relation to coronary artery disease (CAD), but studies differ in their populations, exposure contrasts, and coronary outcomes. We synthesized the available observational evidence on CAD presence and angiographic disease burden. Methods PubMed, Embase, Web of Science, Scopus, CNKI, and Cochrane Library were searched through August 11, 2026. Eligible observational studies examined UHR in relation to CAD presence, coronary stenosis, or anatomical disease burden. Comparable categorical odds ratios (ORs) and correlations with Gensini or SYNTAX scores were synthesized separately using random-effects models. Correlations were pooled after Fisher z transformation. Analyses used restricted maximum likelihood estimation and Knapp–Hartung inference. Results Twenty-four reports were included. Four studies contributed to the CAD-presence/stenosis synthesis (OR 1.94, 95% CI 1.23–3.08; I 2 = 39.2%). Adding one National Health and Nutrition Examination Survey (NHANES) estimate in sensitivity analysis gave an OR of 1.79 (95% CI 1.37–2.34; I 2 < 0.1%). Six studies contributed correlations with angiographic scores (pooled r = 0.508, 95% CI 0.348–0.640; I 2 = 90.3%). Exploratory estimates were r = 0.518 (95% CI 0.271–0.700) for Gensini and r = 0.488 (95% CI 0.138–0.730) for SYNTAX; the subgroup-difference test gave P = 0.836. Restriction to five Spearman studies yielded r = 0.518 (95% CI 0.308–0.680; I 2 = 92.4%). Published categorical-severity odds ratios used different UHR contrasts and were reported separately. Conclusions Higher UHR was associated with CAD presence or stenosis and correlated positively with angiographic burden in the included observational studies. However, the CAD-presence estimate was based on four clinically different studies, and the correlation synthesis was highly heterogeneous. The certainty of both principal associations was very low. These results do not establish causality, a common clinical threshold, or incremental predictive value beyond established risk factors. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/view/CRD420261468348 , PROSPERO, CRD420261468348.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: